Abstract:Introduction Epilepsy is one of the most common neurological disorders worldwide characterized by unpredictable and recurrent seizures, resulting from abnormal brain activity, accompanied by loss of consciousness and control of bowel or bladder function. Objectives A higher risk of comorbid disorders in epilepsy has been reported for psychiatric affective conditions (i.e., depression and schizophrenia), sleep alterations, as well as some gastrointestinal disorders (inflammatory bowel disease and constipation), and lately there is an interest to determine and explain a putative association between functional gastrointestinal disorders (FGID) such as Irritable bowel syndrome (IBS) and epilepsy. Methods In this way, we decided to review the current aspects of the gastrointestinal functional impairments and epilepsy by searching in the literature possible connection mechanisms. Results A handful of studies have only recently reported an increased prevalence of IBS in epilepsy in children, in adults, and conversely a higher incidence of epilepsy in IBS patients at the populational level. Paroxysmal abdominal complaints resulting from seizure activity are present in the abdominal epilepsy syndrome and the link between constipation and seizures has been demonstrated in animal models. Currently, there is no data to directly address the cellular and molecular connections between epilepsy and FGID, but these would probably involve the bidirectional dysregulation of the brain-gut axis with increased afferent processing of visceral nociceptive signals and subsequent hyperalgesia. Conclusions Thus, intestinal dysbiosis may play a role in triggering inflammatory and immune-related mechanisms reported in IBS manifestations and epilepsy, while vagal neuroimunomodulation issues are likely to be involved in both pathologies as well. Conflict of interest The authors are currently supported by a Young Research Teams supporting research grant PN-III-P1-1.1-TE2016-1210, named ”Complex study on oxidative stress status, inflammatory processes and neurological manifestations correlations in irritable bowel synd

INTESTINAL MICROBIOME. EPILEPSY AND THE POSSIBILITY OF EXPANDING ALTERNATIVE THERAPIES

Intestinal Microbiota As an Alternative Therapeutic Target for Epilepsy

Microbiota–Gut–Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics

The Microbiota–Gut–Brain Axis and Epilepsy

The interplay between microbiota and brain-gut axis in epilepsy treatment

The microbiome-gut-brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications

Microbiota-gut-brain axis and ketogenic diet: how close are we to tackling epilepsy?

The gut microbiome and epilepsy

The gut-brain vascular axis in neuroinflammation

Evidences for a Role of Gut Microbiota in Pathogenesis and Management of Epilepsy

A long journey to treat epilepsy with the gut microbiota

Microglia in Microbiota-Gut-Brain Axis: A Hub in Epilepsy

Gastrointestinal functional impairments and epilepsy: Searching the possible connection mechanisms

Is Gut Microbiota a Key Player in Epilepsy Onset? A Longitudinal Study in Drug-Naive Children

Epilepsy and the gut: Perpetrator or victim?

A review of the pathogenesis of epilepsy based on the microbiota-gut-brain-axis theory

Unravelling the critical role of neuroinflammation in epilepsy-associated neuropsychiatric comorbidities: A review

Modulating the gut microbiota ameliorates spontaneous seizures and cognitive deficits in rats with kainic acid-induced status epilepticus by inhibiting inflammation and oxidative stress

A meta-analysis of the changes in the Gut microbiota in patients with intractable epilepsy compared to healthy controls

Unravelling the neuroimmune nexus: insights into epilepsy pathology and the role of S100b protein in brain-gut axis modulation: a literature review

Microbiota-gut-brain axis: A novel potential target of ketogenic diet for epilepsy